Table 1 Characteristics of participants.

From: Association of combustible cigarettes and heated tobacco products use with SARS-CoV-2 infection and severe COVID-19 in Japan: a JASTIS 2022 cross-sectional study

 

All participants (n = 30,130)

Participants infected with SARS-CoV-2 (n = 1117)

Age, n (%)*

    ≤ 34 years

8450 (28.0)

657 (58.8)

    35–49 years

7696 (25.5)

289 (25.9)

    50–64 years

6661 (22.1)

108 (9.7)

    ≥ 65 years

7323 (24.3)

62 (5.6)

Sex, n (%)

    Male

14,718 (48.8)

714 (63.9)

    Female

15,412 (51.2)

403 (36.1)

Tobacco use status, n (%)

    Never-user

16,210 (53.8)

380 (34.0)

    Former user (combustible cigarettes or HTPs)

6584 (21.9)

145 (13.0)

    Current user of combustible cigarettes

3571 (11.9)

92 (8.2)

    Current user of HTPs

1558 (5.2)

75 (6.7)

    Current dual user (combustible cigarettes and HTPs)

2206 (7.3)

425 (38.0)

Occupation, n (%)

    Student/unemployed/retiree

10,283 (34.1)

157 (14.1)

    Healthcare worker

2265 (7.5)

94 (8.4)

    Remote worker

1521 (5.0)

85 (7.6)

    Other worker

16,061 (53.3)

781 (69.9)

Household annual income, n (%)

    Below average

14,651 (48.6)

545 (48.8)

    Above average (higher)

8392 (27.9)

374 (33.5)

    Did not know/did not want to answer

7087 (23.5)

198 (17.7)

Education, n (%)

    Junior high school/high school

15,614 (51.8)

555 (49.7)

    University/technical school or more

14,516 (48.2)

561 (50.2)

Housing tenure, n (%)

    Own house

22,665 (75.2)

728 (65.2)

    Rental house

6903 (22.9)

359 (32.1)

    Other (freeloader/rootless)

562 (1.9)

30 (2.7)

Living in prefectures under alert, n (%)

    No

11,997 (39.8)

315 (28.2)

    Yes

18,133 (60.2)

802 (71.8)

Household members other than the participant, n (%)

    None (living alone)

5091 (16.9)

249 (22.3)

    Adult(s) only

16,641 (55.2)

425 (38.0)

    Living with a child (children)

8398 (27.9)

443 (39.7)

Interacting with people living separately at least once a week, n (%)

    No

19,453 (64.6)

491 (44.0)

    Yes

10,677 (35.4)

625 (56.0)

Total METs per day, n (%)

    Below average

22,489 (74.6)

607 (54.3)

    Above average (more active)

7641 (25.4)

510 (45.7)

Alcohol consumption, n (%)

  

    Never drinker

13,096 (43.5)

394 (35.3)

    Ever drinker

17,034 (56.5)

723 (64.7)

Comorbidities, n (%)

    None

18,746 (62.2)

671 (60.1)

    One comorbidity

6558 (21.8)

154 (13.8)

    Two or more comorbidities

4826 (16.0)

292 (26.1)

      Obesity (BMI ≥ 30 kg/m2)

1127 (3.7)

42 (3.8)

      Diabetes

2170 (7.2)

161 (14.4)

      Hypertension

7116 (23.6)

298 (26.7)

      Hyperlipidemia

4346 (14.4)

198 (17.7)

      Cardiovascular disease

809 (2.7)

135 (12.1)

      Cerebrovascular disease

466 (1.5)

145 (13.0)

      Chronic kidney disease

509 (1.7)

138 (12.4)

      Chronic hepatitis or cirrhosis

425 (1.4)

148 (13.2)

      Chronic obstructive pulmonary disease

369 (1.2)

146 (13.1)

      Asthma

1175 (3.9)

181 (16.2)

      Malignant tumor

717 (2.4)

152 (13.6)

      Immunodeficiency§

678 (2.3)

140 (12.5)

Engagement in infection prevention measures, n (%)

    Below average

11,476 (38.1)

671 (60.1)

    Above average (more careful)

18,654 (61.9)

446 (39.9)

SARS-CoV-2 vaccination status, n (%)

    No or one time of mRNA vaccination

4329 (14.4)

239 (21.4)

    Two or three times of vaccination

25,801 (85.6)

878 (78.6)

Year of infection, n (%)

    Over one year prior to the survey

591 (52.9)

    Within the preceding year

546 (48.9)

Hospitalization due to COVID-19, n (%)

    No

616 (55.1)

    Yes

501 (44.9)

Oxygen administration due to COVID-19, n (%)

    No

641 (57.4)

    Yes

476 (42.6)

  1. *Percentages in all participants (left column)/participants infected with SARS-CoV-2 (right column) (same as below). 21 prefectures that had been declared the State of Emergency more than once. Under 18 years old. §Include use of corticosteroids, biologics, and immunosuppressive drugs. Percentage of 12 infection prevention behaviors being performed. n number (weighted by inverse probability weighting), SARS-CoV-2 severe acute respiratory syndrome coronavirus 2, HTPs heated tobacco products, METs metabolic equivalents, BMI body mass index, mRNA messenger ribonucleic acid, COVID-19 coronavirus disease 2019.